Back

The use of lipid-lowering medication after diagnostic imaging procedures in patients with chest pain

28 August 2022 (11:15 - 12:00)
Organised by:
Congress Presentation Part of: Coronary artery disease - Noninvasive diagnostic methods Noninvasive Diagnostic Methods ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Teemu Maaniitty

University of Turku, Turku (Finland)

5 More presentations in this session

Presentation thumbnail
Magnetocardiography as a noninvasive diagnostic strategy for suspected coronary microvascular dysfunction
Doctor O. Quesada (Cincinnati, US)
Abstract Slides
Presentation thumbnail
Noninvasive evaluation of coronary velocity reserve: Need for correction of the sympathetic tone.
Doctor I. Armenis (Maroussi-Athens, GR)
Abstract Slides
Presentation thumbnail
Prognostic value of stress cardiac magnetic resonance at 3 Tesla in patients with known or suspected coronary artery disease
Doctor S. Punawakul (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Stent expansion evaluated by optical coherence tomography and subsequent outcomes
Doctor B. Lee (Seongnam, KR)
Abstract Slides
Presentation thumbnail
The predictive value of regional 2D longitudinal strain in determining the localization of coronary artery stenosis in NSTE-ACS patients
Doctor S. Krizanac (Mistelbach, AT)
Abstract Slides

Access the full session

Session thumbnail
Coronary artery disease - Noninvasive diagnostic methods

The Event

Event poster

ESC Congress 2022

28 August 2022 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Aspirin and statin use in primary prevention after coronary artery calcium score
13 April 2023
thumbnail
Congress Presentation
Myocardial perfusion findings evaluated by gated-SPECT in dyslipidemic very high-risk patients.
9 May 2021
thumbnail
Congress Presentation
Immune checkpoint inhibition increases aortic inflammation on 18F-FDG PET/CT: a retrospective cohort study in patients with Merkel cell carcinoma receiving avelumab
21 June 2025
thumbnail
Congress Presentation
STEMI and lipid management: are current prescriptions at discharge enough to meet target goals?
15 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources